The present invention relates generally to ultrasound focusing and, more particularly, to calibrating magnetic-resonance-guided focused ultrasound systems.
Ultrasound penetrates well through soft tissues and, due to its short wavelengths, can be focused to spots with dimensions of a few millimeters. As a consequence of these properties, ultrasound can and has been used for a variety of diagnostic and therapeutic medical purposes, including ultrasound imaging and noninvasive surgery. For example, focused ultrasound may be used to ablate diseased (e.g., cancerous) tissue without causing significant damage to surrounding healthy tissue. The noninvasive nature of ultrasound surgery is particularly appealing for the treatment of, for example, brain tumors.
An ultrasound focusing system generally utilizes an acoustic transducer surface, or an array of transducer surfaces, to generate an ultrasound beam. In transducer arrays, the individual surfaces are typically individually controllable, i.e., their vibration phases and/or amplitudes can be set independently of one another, allowing the beam to be steered in a desired direction and focused at a desired distance. In medical applications, the target location of the ultrasound focus is often determined using magnetic resonance imaging (MRI). In brief, MRI involves placing a subject, such as the patient, into a static magnetic field, thus aligning the spins of hydrogen nuclei in the tissue, and then applying radio-frequency electromagnetic pulses to temporarily destroy the alignment, inducing a response signal. Different tissues produce different response signals, resulting in a contrast among theses tissues in MR images. Thus, MRI may be used to visualize, for example, a brain tumor, and determine its location relative to the patient's skull. An ultrasound transducer system, such as an array of transducers attached to a housing, may then be placed on the patient's head, and the transducers driven so as to focus ultrasound onto the tumor. This method is referred to as magnetic-resonance-guided focusing of ultrasound (MRgFUS).
In MRgFUS, the treatment target is defined in magnetic resonance (MR) coordinates. To enable directing the ultrasound focus onto this target, the location and orientation of the transducer(s) need to be ascertained in MR coordinates as well. The transducer coordinates may be measured directly in the MR coordinate system using MR trackers—e.g., fiducials visible in MR images—that are rigidly attached to the transducer system, or have an otherwise fixed and known relative location with respect to the transducer(s). MR trackers may be implemented in various ways, for example, as MRI markers or microcoils.
Ideally, the acoustic surface and the MR trackers would be perfectly placed and aligned with respect to each other. In practice, however, mechanical tolerances in production are inevitable, and the relative positions of the transducer(s) and the MR trackers generally deviate from the nominal relative positions due to these “production errors.” As a result, if a transducer array is driven based on the nominal relative positions, the ultrasound focus will deviate from the intended focus. To ensure that the ultrasound focus more accurately coincides with the intended target, there is, accordingly, a need to quantify the effect of production errors on the accuracy of targeting.
The present invention provides, in various embodiments, systems and methods for calibrating MR-guided focused ultrasound systems to enable estimating, and compensating for, misalignment parameters between MR trackers and ultrasound transducers of a phased array. Generally, the calibration involves driving the phased array at different sets of transducer phases and/or amplitudes (hereinafter referred to as sonication geometries) to address different targets, and measuring the targeting errors (i.e., the deviations of the ultrasound focus location from the expected location) for these different sonication geometries. The measurements may be performed on an acoustic phantom, which may be made of a gel. The combined information about the sonication geometries and associated targeting errors, along with information about the experimental setup, allows the production errors to be estimated. In subsequent MRgFUS, these estimates may serve to compute adjustments in the sonication geometry so as to focus the ultrasound at the intended target location. Thus, embodiments of the invention improve the accuracy MRgFUS. In some embodiments, the ultrasound focus will coincide with the target location within a tolerance of 1 mm.
In a first aspect, therefore, various embodiments of the invention provide a method for calibrating a MRgFUS system. The method includes providing a phased array of ultrasound transducers that has at least one associated MR tracker (e.g., a micro-coil or MRI marker) with a fixed position relative to the array, and establishing MR coordinates of the MR trackers. The MR trackers and the array may be part of a single rigid structure. The method further includes creating an ultrasound focus with the phased array for each of a plurality of sonication schemes, and establishing parameters indicative of MR coordinates of the ultrasound focus. These parameters may be, for example, the MR coordinates of the ultrasound focus, or coordinates of one or more projections of the ultrasound focus. The ultrasound focus may be created in a phantom, and the parameters may be established using any suitable MRI technique, for example, thermal MRI or acoustic-radiation-force MRI. Based at least in part on the parameters, a geometric relationship between the ultrasound transducers and the MR trackers is then determined. The determination of the geometric relationship may further be based on the sonication schemes.
In some embodiments, the geometric relationship includes coordinates of the MR trackers in a transducer coordinate system. Determining the geometric relationship may include determining a transformation between the MR coordinate system and the transducer coordinate system that is based, at least in part, on the parameters indicative of the MR coordinates of the ultrasound foci and on the sonication schemes, and using the transformation to determine the coordinates of the MR trackers in the transducer coordinate system.
In some embodiments, the geometric relationship includes production errors indicative of a deviation of the fixed relative positions between the MR trackers and the transducers from nominal relative positions. In this case, a transformation between the parameters and the production errors may be determined based, at least in part, on the sonication scheme. Further, a linear estimation method (e.g., a least square method) may be applied to the transformation and the ultrasound focus parameters to determine the production errors.
In a second aspect, a method for operating a magnetic-resonance-guided focused-ultrasound system is provided. Embodiments of the method include providing a phased array of ultrasound transducers with one or more associated MR trackers, and calibrating this system by establishing MR coordinates of the MR trackers, creating ultrasound foci for a plurality of sonication schemes and establishing parameters indicative of MR coordinates of the ultrasound foci, and determining a geometric relationship between the ultrasound transducers and the MR trackers based, at least in part, on the parameters. The method further includes operating the magnetic-resonance-guided focused-ultrasound system by focusing ultrasound into a target region with MR coordinates, based on the geometric relationship.
In a third aspect, a system for calibrating a magnetic-resonance-guided ultrasound-focusing system is provided. Embodiments of the system include a phased array of ultrasound transducers, an MRI apparatus, and a control facility. Associated with the ultrasound transducer array is at least one MR tracker, whose position is fixed relative to the array. The functionalities of the control facility include driving the phased array according to a sonication scheme to generate an ultrasound focus, receiving MR imaging data indicative of MR coordinates of the ultrasound focus and the MR trackers, and determining a geometric relationship between the ultrasound transducers and the MR trackers based (at least in part) on the MR imaging data. The system may further include (or operate on) a phantom in which the ultrasound focus is generated.
In a fourth aspect, various embodiments of the invention provide a magnetic-resonance-guided ultrasound-focusing system including a phased array of ultrasound transducers with associated MR trackers, an MR imaging apparatus, a user interface facilitating selection of a target region in MR coordinates, and a control facility. The functionalities of the control facility include driving the phased array according to a sonication scheme to generate an ultrasound focus, receiving MR imaging data indicative of MR coordinates of the ultrasound focus and the MR trackers, determining a geometric relationship between the ultrasound transducers and the MR trackers based (at least in part) on the MR imaging data, and operating the magnetic-resonance-guided focused-ultrasound system by focusing ultrasound into the target region based on the geometric relationship.
The foregoing discussion and the following detailed description of embodiments of the invention can more readily be understood in conjunction with the accompanying drawings wherein:
The present invention is generally directed to the calibration of MRgFUS systems. An exemplary MRgFUS system 100 is illustrated schematically in
The transducers 102 are separately controllable, i.e., they are each capable of emitting ultrasound waves at amplitudes and/or phases that are independent of the amplitudes and/or phases of the other transducers. A control facility 106 serves to drive the transducers 102. For n transducer elements, the control facility 106 may contain n control circuits each comprising an amplifier and a phase delay circuit, each control circuit driving one of the transducer elements. The control facility may split a radio frequency (RF) input signal, typically in the range from 0.1 MHz to 4 MHz, into n channels for the n control circuit. It may be configured to drive the individual transducer elements 102 of the array at the same frequency, but at different phases and different amplitudes so that they collectively produce a focused ultrasound beam. The control facility 106 desirably provides computational functionality, which may be implemented in software, hardware, firmware, hardwiring, or any combination thereof, to compute the required phases and amplitudes for a desired focus location. In general, the control facility may include several separable apparatus, such as a frequency generator, a beamformer containing the amplifier and phase delay circuitry, and a computer (e.g., a general-purpose computer) performing the computations and communicating the phases and amplitudes for the individual transducers 102 to the beamformer. Such systems are readily available or can be implemented without undue experimentation.
The MRgFUS system 100 further includes an MRI apparatus 108 in communication with the control facility 106. An exemplary apparatus 108 is illustrated in more detail in
Referring again to
Typically, the relative positions of MR trackers 110 and transducers 102 are only approximately known. In order to obtain more accurate values for the relative positions, or their difference from the nominal, assumed values (i.e., the production errors), the system 100 may be calibrated. During calibration, the array of transducers 102 is attached to or located about an acoustic phantom 116, wherein an ultrasound focus may be generated.
The location of the ultrasound focus 112 in the phantom 116 depends on the particular sonication scheme as well as quantities characterizing the experimental setup, which may include, e.g., the speed of sound in the phantom, the incidence angle of ultrasound waves onto the surface of the phantom 116, and/or measurement distortions associated with the MRI apparatus 108. The relationship between the targeting errors and the production errors likewise depends on the sonication scheme and the setup quantities (i.e., nominal setup quantities and unknown setup errors).
Although the production and setup errors are not known a priori, the transfer function itself is known from the nominal setup quantities and the selected sonication scheme. The transfer function may be given in the form of an algorithm for computing, for any hypothetical production error, the resulting targeting error. An exemplary such algorithm may involve (i) determining the position(s) and orientation(s) of the transducer surface(s) from their nominal relative positions to the trackers and the production errors; (ii) computing the location of the ultrasound focus based on the transducer location(s) and orientation(s) and the sonication scheme; (iii) determining “nominal” position(s) and orientation(s) of the transducer surface(s) from their nominal relative positions to the trackers alone, assuming that the production errors are zero; (iv) computing the location of the ultrasound focus based on the “nominal” transducer location(s) and orientation(s) and the sonication scheme; and (v) computing the difference between the two focus locations. Methods for computing the location of an ultrasound focus generated by a phased array of transducers driven according to a particular sonication scheme are described, for example, in U.S. patent application Ser. No. 12/425,698, filed Apr. 17, 2009, the entire contents of which are hereby incorporated herein by reference in their entirety.
Provided that the experimental setup does not change, the targeting errors are repeatable for each particular sonication scheme. By generating ultrasound foci in the phantom in accordance with a suitable set of different sonication schemes, and measuring the resulting targeting errors, production errors may be ascertained, or rendered “observable,” as the term is used in estimation theory. Assuming that three-dimensional MR coordinates of the ultrasound focus can be determined for each sonication scheme, three sonications are needed to determine the position of the transducer in three dimensions. If only partial information can be derived from each sonication, however, the required number of sonication schemes is higher. An increased number of sonication schemes may also serve to improve statistics and reduce the effect of random errors. On the other hand, if constraints are placed on the positions of the transducers, or if not all of the positional information is desired (e.g., if the rotation of the transducer about itself is not relevant), fewer sonication schemes may suffice.
Accordingly, in various embodiments, the present invention facilitates determination of the relative positions between ultrasound transducers 102 and MR trackers 110 or, in other words, the relationship between ultrasound and MR coordinates. Methods in accordance with the invention involve, first, attaching the phased array of transducers 102 to the acoustic phantom 116, and introducing the arrangement into the MRI apparatus 108. Next, various sonication schemes are applied to the transducers 102, and the phantom and transducer setup is imaged using MRI techniques. Suitable imaging techniques include, for example, thermal imaging and acoustic radiation force imaging. Image acquisition may be three-dimensional or may, alternatively, provide a set of one- or two-dimensional images, which may be suitable for constructing a three-dimensional image. In the MR images, the focus location and/or targeting errors may be measured in terms of MR coordinates or related parameters. For example, the focal spot may be projected into a specific image plane, and the projection coordinates of the focus determined. The parameters indicative of the focus and/or targeting errors for the various sonication schemes may then be processed to estimate the relationship between the ultrasound and MR coordinates. This estimation step may be implemented in various ways.
In one approach, the relationship between production (and setup) and targeting errors is modeled with a linear transfer function. Such linear approximations are appropriate when the input and output variables are small, which is usually the case for the production errors and resulting targeting errors. A linear transfer function can be expressed as a matrix. In
The equations for the different sonication schemes (k) can all be combined into one linear system of equations, symbolically described in terms of a matrix equation: Mes=MT*PE+Noise, wherein Mes is a vector of vectors Mes(k), and MT is a block matrix comprising the individual blocks Mk*Tk. This system of linear equations may be solved using linear estimation methods, such as, e.g., least-square methods, minimum-variance, weighted-least-squares, maximum-likelihood, L1-regression, and/or best-linear-estimation methods. Utilizing a least-square method, for example, the pseudo-inverse matrix MT# of the product of MT and its transpose may be computed according to MT#=(MTT*MT)−1, and then the production errors may be estimated by multiplying the pseudo-inverse matrix to the vector of measurements: PEestimated=MT#*MTT*Mes.
An alternative approach involves determining a transformation between the MR coordinate system and the transducer coordinate system based on MR coordinates of ultrasound foci generated at certain locations with respect to the transducers and, therefore, at known transducer coordinates. Once this transformation is found, it can be applied to the MR tracker positions in the MR coordinate system to yield the MR tracker positions in the ultrasound coordinate system. This approach does not include determining target errors and, therefore, does not require initial estimates of MR tracker locations relative to the transducers.
The transformation between the transducer and the MR coordinate systems is defined by a geometric relationship therebetween. This relationship, in turn, can be determined from the transducer and MR coordinates of a sufficient number of suitably located ultrasound foci. In practice, however, it is not trivial to find the foci. Firstly, the ultrasound focus spot is usually elongated along the direction of the ultrasound beam. Secondly, a correct measurement of the focus location in the MR coordinate system requires an MR image that goes through the center of the ultrasound focus. In two-dimensional MR imaging, finding this center may require many scans, and constitute a cumbersome process. To overcome these difficulties, in one embodiment, the ultrasound focus locations are confined to two planes, as illustrated in
To find the transformation between the MR and transducer coordinate systems, the MR coordinates of the measured (apparent) foci are sorted into those that belong to foci in the PR plane and those that belong to foci in the QR plane. From these data, a best fit to each of the two point collections defines the planes in the MR coordinate system. The intersection of the QR and PR planes defines the R direction. The R direction and the PR plane together then define the P direction, and, similarly, the R direction and the QR plane together define the Q direction. The only parameter that remains to be determined is the position of the origin along the R axis. This parameter can be determined from a best fit for an origin that would produce the measured focus positions, or from one or a few additional sonications.
Although the present invention has been described with reference to specific details, it is not intended that such details should be regarded as limitations upon the scope of the invention, except as and to the extent that they are included in the accompanying claims.
Number | Name | Date | Kind |
---|---|---|---|
2795709 | Camp | Jun 1957 | A |
3142035 | Harris | Jul 1964 | A |
3942150 | Booth et al. | Mar 1976 | A |
3974475 | Burckhardt et al. | Aug 1976 | A |
3992693 | Martin et al. | Nov 1976 | A |
4000493 | Spaulding et al. | Dec 1976 | A |
4074564 | Anderson | Feb 1978 | A |
4206653 | Lemay | Jun 1980 | A |
4339952 | Foster | Jul 1982 | A |
4454597 | Sullivan | Jun 1984 | A |
4478083 | Hassler et al. | Oct 1984 | A |
4505156 | Questo | Mar 1985 | A |
4526168 | Hassler et al. | Jul 1985 | A |
4537074 | Dietz | Aug 1985 | A |
4549533 | Cain et al. | Oct 1985 | A |
4554925 | Young | Nov 1985 | A |
4636964 | Jacobs et al. | Jan 1987 | A |
4662222 | Johnson | May 1987 | A |
4858597 | Kurtze et al. | Aug 1989 | A |
4865042 | Umemura et al. | Sep 1989 | A |
4888746 | Wurster et al. | Dec 1989 | A |
4889122 | Watmough et al. | Dec 1989 | A |
4893284 | Magrane | Jan 1990 | A |
4893624 | Lele | Jan 1990 | A |
4937767 | Reuschel et al. | Jun 1990 | A |
5209221 | Riedlinger | May 1993 | A |
5211160 | Talish et al. | May 1993 | A |
5247935 | Cline et al. | Sep 1993 | A |
5271400 | Dumoulin et al. | Dec 1993 | A |
5275165 | Ettinger et al. | Jan 1994 | A |
5291890 | Cline et al. | Mar 1994 | A |
5307812 | Hardy et al. | May 1994 | A |
5307816 | Hashimoto et al. | May 1994 | A |
5318025 | Dumoulin et al. | Jun 1994 | A |
5323779 | Hardy et al. | Jun 1994 | A |
5327884 | Hardy et al. | Jul 1994 | A |
5329930 | Thomas, III et al. | Jul 1994 | A |
5339282 | Kuhn et al. | Aug 1994 | A |
5368031 | Cline et al. | Nov 1994 | A |
5368032 | Cline et al. | Nov 1994 | A |
5379642 | Reckwerdt et al. | Jan 1995 | A |
5391140 | Schaetzle et al. | Feb 1995 | A |
5413550 | Castel | May 1995 | A |
5435312 | Spivey et al. | Jul 1995 | A |
5443068 | Cline et al. | Aug 1995 | A |
5474071 | Chapelon et al. | Dec 1995 | A |
5485839 | Aida et al. | Jan 1996 | A |
5490840 | Uzgiris et al. | Feb 1996 | A |
5507790 | Weiss | Apr 1996 | A |
5520188 | Hennige et al. | May 1996 | A |
5526814 | Cline et al. | Jun 1996 | A |
5549638 | Burdette | Aug 1996 | A |
5553618 | Suzuki et al. | Sep 1996 | A |
5557438 | Schwartz et al. | Sep 1996 | A |
5573497 | Chapelon | Nov 1996 | A |
5582578 | Zhong et al. | Dec 1996 | A |
5590653 | Aida et al. | Jan 1997 | A |
5590657 | Cain et al. | Jan 1997 | A |
5601526 | Chapelon et al. | Feb 1997 | A |
5605154 | Ries et al. | Feb 1997 | A |
5617371 | Williams | Apr 1997 | A |
5617857 | Chader et al. | Apr 1997 | A |
5643179 | Fujimoto | Jul 1997 | A |
5662170 | Donovan et al. | Sep 1997 | A |
5665054 | Dory | Sep 1997 | A |
5666954 | Chapelon et al. | Sep 1997 | A |
5676673 | Ferre et al. | Oct 1997 | A |
5687729 | Schaetzle | Nov 1997 | A |
5694936 | Fujimoto et al. | Dec 1997 | A |
5711300 | Schneider et al. | Jan 1998 | A |
5722411 | Suzuki et al. | Mar 1998 | A |
5739625 | Falcus | Apr 1998 | A |
5743863 | Chapelon | Apr 1998 | A |
5752515 | Jolesz et al. | May 1998 | A |
5759162 | Oppelt et al. | Jun 1998 | A |
5762616 | Talish | Jun 1998 | A |
5769790 | Watkins et al. | Jun 1998 | A |
5810008 | Dekel et al. | Sep 1998 | A |
5817036 | Anthony et al. | Oct 1998 | A |
5831739 | Ota | Nov 1998 | A |
5873845 | Cline et al. | Feb 1999 | A |
5897495 | Aida et al. | Apr 1999 | A |
5938600 | Van Vaals et al. | Aug 1999 | A |
5938608 | Bieger et al. | Aug 1999 | A |
5947900 | Derbyshire et al. | Sep 1999 | A |
5984881 | Ishibashi et al. | Nov 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6023636 | Wendt et al. | Feb 2000 | A |
6042556 | Beach et al. | Mar 2000 | A |
6071239 | Cribbs et al. | Jun 2000 | A |
6113558 | Rosenschein et al. | Sep 2000 | A |
6113559 | Klopotek | Sep 2000 | A |
6128522 | Acker et al. | Oct 2000 | A |
6128958 | Cain | Oct 2000 | A |
6193659 | Ramamurthy et al. | Feb 2001 | B1 |
6242915 | Hurd | Jun 2001 | B1 |
6246896 | Dumoulin et al. | Jun 2001 | B1 |
6263230 | Haynor et al. | Jul 2001 | B1 |
6267734 | Ishibashi et al. | Jul 2001 | B1 |
6289233 | Dumoulin et al. | Sep 2001 | B1 |
6309355 | Cain et al. | Oct 2001 | B1 |
6317619 | Boernert et al. | Nov 2001 | B1 |
6322527 | Talish | Nov 2001 | B1 |
6334846 | Ishibashi et al. | Jan 2002 | B1 |
6374132 | Acker et al. | Apr 2002 | B1 |
6392330 | Zloter et al. | May 2002 | B1 |
6397094 | Ludeke et al. | May 2002 | B1 |
6413216 | Cain et al. | Jul 2002 | B1 |
6419648 | Vitek et al. | Jul 2002 | B1 |
6424597 | Bolomey et al. | Jul 2002 | B1 |
6425867 | Vaezy et al. | Jul 2002 | B1 |
6428532 | Doukas et al. | Aug 2002 | B1 |
6461314 | Pant et al. | Oct 2002 | B1 |
6475150 | Haddad | Nov 2002 | B2 |
6478739 | Hong | Nov 2002 | B1 |
6506154 | Ezion et al. | Jan 2003 | B1 |
6506171 | Vitek et al. | Jan 2003 | B1 |
6511428 | Azuma et al. | Jan 2003 | B1 |
6522142 | Freundlich | Feb 2003 | B1 |
6523272 | Morales | Feb 2003 | B1 |
6554826 | Deardorff | Apr 2003 | B1 |
6559644 | Froundlich et al. | May 2003 | B2 |
6566878 | Komura et al. | May 2003 | B1 |
6582381 | Marantz et al. | Jun 2003 | B1 |
6599256 | Acker et al. | Jul 2003 | B1 |
6612988 | Maor et al. | Sep 2003 | B2 |
6613004 | Vitek et al. | Sep 2003 | B1 |
6613005 | Friedman et al. | Sep 2003 | B1 |
6618608 | Watkins et al. | Sep 2003 | B1 |
6618620 | Freundlich et al. | Sep 2003 | B1 |
6626854 | Friedman et al. | Sep 2003 | B2 |
6626855 | Weng et al. | Sep 2003 | B1 |
6629929 | Jago et al. | Oct 2003 | B1 |
6645162 | Friedman et al. | Nov 2003 | B2 |
6652461 | Levkovitz | Nov 2003 | B1 |
6666833 | Friedman et al. | Dec 2003 | B1 |
6676601 | Lacoste et al. | Jan 2004 | B1 |
6679855 | Horn et al. | Jan 2004 | B2 |
6705994 | Vortman et al. | Mar 2004 | B2 |
6719694 | Weng et al. | Apr 2004 | B2 |
6733450 | Alexandrov et al. | May 2004 | B1 |
6735461 | Vitek et al. | May 2004 | B2 |
6761691 | Tsuzuki | Jul 2004 | B2 |
6770031 | Hynynen et al. | Aug 2004 | B2 |
6770039 | Zhong et al. | Aug 2004 | B2 |
6788619 | Calvert | Sep 2004 | B2 |
6790180 | Vitek | Sep 2004 | B2 |
6824516 | Batten et al. | Nov 2004 | B2 |
6951540 | Ebbini et al. | Oct 2005 | B2 |
6961606 | DeSilets et al. | Nov 2005 | B2 |
7001379 | Behl et al. | Feb 2006 | B2 |
7077820 | Kadziauskas et al. | Jul 2006 | B1 |
7094205 | Marmarelis | Aug 2006 | B2 |
7128711 | Medan et al. | Oct 2006 | B2 |
7155271 | Halperin et al. | Dec 2006 | B2 |
7175596 | Vitek et al. | Feb 2007 | B2 |
7175599 | Hynynen et al. | Feb 2007 | B2 |
7264592 | Shehada | Sep 2007 | B2 |
7264597 | Cathignol | Sep 2007 | B2 |
7267650 | Chow et al. | Sep 2007 | B2 |
7344509 | Hynynen et al. | Mar 2008 | B2 |
7377900 | Vitek et al. | May 2008 | B2 |
7452357 | Vlegele et al. | Nov 2008 | B2 |
7462488 | Madsen et al. | Dec 2008 | B2 |
7505805 | Kuroda | Mar 2009 | B2 |
7505808 | Anderson et al. | Mar 2009 | B2 |
7510536 | Foley et al. | Mar 2009 | B2 |
7511501 | Wexler | Mar 2009 | B2 |
7535794 | Prus et al. | May 2009 | B2 |
7553284 | Vaitekunas | Jun 2009 | B2 |
7603162 | Danz et al. | Oct 2009 | B2 |
7611462 | Vortman et al. | Nov 2009 | B2 |
7652410 | Prus | Jan 2010 | B2 |
7699780 | Vitek et al. | Apr 2010 | B2 |
20010031922 | Weng et al. | Oct 2001 | A1 |
20020035779 | Krieg et al. | Mar 2002 | A1 |
20020082589 | Friedman et al. | Jun 2002 | A1 |
20020188229 | Ryaby | Dec 2002 | A1 |
20030004439 | Pant et al. | Jan 2003 | A1 |
20030060820 | Maguire et al. | Mar 2003 | A1 |
20030187371 | Vortman et al. | Oct 2003 | A1 |
20040030227 | Littrup et al. | Feb 2004 | A1 |
20040030251 | Ebbini et al. | Feb 2004 | A1 |
20040068186 | Ishida et al. | Apr 2004 | A1 |
20040122323 | Vortman et al. | Jun 2004 | A1 |
20040147919 | Behl et al. | Jul 2004 | A1 |
20040199068 | Bucholz et al. | Oct 2004 | A1 |
20040210134 | Hynynen et al. | Oct 2004 | A1 |
20040236253 | Vortman et al. | Nov 2004 | A1 |
20040267126 | Takeuchi | Dec 2004 | A1 |
20050033201 | Takahashi et al. | Feb 2005 | A1 |
20050096542 | Weng et al. | May 2005 | A1 |
20050131301 | Peszynski et al. | Jun 2005 | A1 |
20050203444 | Schonenberger et al. | Sep 2005 | A1 |
20050240126 | Foley et al. | Oct 2005 | A1 |
20050251046 | Yamamoto et al. | Nov 2005 | A1 |
20060052661 | Gannot et al. | Mar 2006 | A1 |
20060052701 | Carter et al. | Mar 2006 | A1 |
20060052706 | Hynynen et al. | Mar 2006 | A1 |
20060058671 | Vitek et al. | Mar 2006 | A1 |
20060058678 | Vitek et al. | Mar 2006 | A1 |
20060079773 | Mourad et al. | Apr 2006 | A1 |
20060106300 | Seppenwoolde et al. | May 2006 | A1 |
20060173385 | Lidgren et al. | Aug 2006 | A1 |
20060184069 | Vaitekunas | Aug 2006 | A1 |
20060206105 | Chopra et al. | Sep 2006 | A1 |
20060229594 | Francischelli et al. | Oct 2006 | A1 |
20070016013 | Camus | Jan 2007 | A1 |
20070016039 | Vortman et al. | Jan 2007 | A1 |
20070055140 | Kuroda | Mar 2007 | A1 |
20070066897 | Sekins et al. | Mar 2007 | A1 |
20070073135 | Lee et al. | Mar 2007 | A1 |
20070098232 | Matula et al. | May 2007 | A1 |
20070167781 | Vortman et al. | Jul 2007 | A1 |
20070197918 | Vitek et al. | Aug 2007 | A1 |
20070219470 | Talish et al. | Sep 2007 | A1 |
20080027342 | Rouw et al. | Jan 2008 | A1 |
20080031090 | Prus et al. | Feb 2008 | A1 |
20080033278 | Assif | Feb 2008 | A1 |
20080082026 | Schmidt et al. | Apr 2008 | A1 |
20080108900 | Lee et al. | May 2008 | A1 |
20080183077 | Moreau-Gobard et al. | Jul 2008 | A1 |
20080228081 | Becker et al. | Sep 2008 | A1 |
20080249408 | Palmeri et al. | Oct 2008 | A1 |
20080292194 | Schmidt et al. | Nov 2008 | A1 |
20080312562 | Routh et al. | Dec 2008 | A1 |
20090088623 | Vortman et al. | Apr 2009 | A1 |
20090096450 | Roland | Apr 2009 | A1 |
20100056962 | Vortman et al. | Mar 2010 | A1 |
Number | Date | Country |
---|---|---|
4345308 | Feb 2001 | DE |
10102317 | Aug 2002 | DE |
1132054 | Sep 2001 | EP |
1582886 | Oct 2005 | EP |
151073 | Nov 2005 | EP |
1774920 | Apr 2007 | EP |
1790384 | May 2007 | EP |
2806611 | Sep 2001 | FR |
11313833 | Nov 1999 | JP |
WO-9100059 | Jan 1991 | WO |
WO-9852465 | Nov 1998 | WO |
WO-0031614 | Jun 2000 | WO |
WO-0031614 | Jun 2000 | WO |
WO-0143640 | Jun 2001 | WO |
WO-0158337 | Aug 2001 | WO |
WO-0166189 | Sep 2001 | WO |
WO-0180709 | Nov 2001 | WO |
WO-02058791 | Aug 2002 | WO |
WO-03013654 | Feb 2003 | WO |
WO-03070105 | Aug 2003 | WO |
WO-03097162 | Nov 2003 | WO |
WO-03098232 | Nov 2003 | WO |
WO-2004093686 | Nov 2004 | WO |
WO-200558029 | Jun 2005 | WO |
WO-2005058029 | Jun 2005 | WO |
WO-2006018837 | Feb 2006 | WO |
WO-2006025001 | Mar 2006 | WO |
WO-2006087649 | Aug 2006 | WO |
WO-2006119572 | Nov 2006 | WO |
WO-2007073551 | Jun 2007 | WO |
WO-2007093998 | Aug 2007 | WO |
WO-2008039449 | Apr 2008 | WO |
WO-2008050278 | May 2008 | WO |
WO-200875203 | Jun 2008 | WO |
WO-2008075203 | Jun 2008 | WO |
WO-2008119054 | Oct 2008 | WO |
WO-2009055587 | Apr 2009 | WO |
WO-2009094554 | Jul 2009 | WO |
Entry |
---|
Botros et al., “A hybrid computational model for ultrasound phased-array heating in presence of strongly scattering obstacles,” IEEE Trans. On Biomed. Eng., vol. 44, No. 11, pp. 1039-1050 (Nov. 1997). |
Cain et al., “Concentric-ring and Sector-vortex Phased-array Applicators for Ultrasound Hperthermia,” IEEE Trans. On Microwave Theory & Techniques, vol. MTT-34, No. 5, pp. 542-551 (May 1986). |
Chen et al., “MR Acoustic Radiation Force Imaging: Comparison of Encoding Gradients.”. |
Cline et al., “Focused US system for MR imaging-guide tumor ablation,” Radiology, v. 194, No. 3, pp. 731-738 (Mar. 1995). |
Cline et al., “MR Temperature mapping of focused ultrasound surgery,” Magnetic Resonance in Medicine, vol. 32, No. 6, pp. 628-636 (1994). |
Cline et al., “Simultaneous magnetic resonance phase and magnitude temperature maps in muscle,” Magnetic Resonance in Medicine, vol. 35, No. 3, pp. 309-315 (Mar. 1996). |
Daum et al., “Design and evaluation of a feedback based phased array system for ultrasound surgery,” IEEE Trans. Ultrason. Ferroelec. Freq. Control, vol. 45, No. 2, pp. 431-434 (1998). |
de Senneville et al., “Real-time adaptive methods for treatment of mobile organs by MRI-controlled high-intensity focussed Ultrasound,” Magnetic Resonance in Medicine 57:319-330 (2007). |
Fjield et al, “The Combined Concentric-ring and Sector-vortex Phased Array for MRI Guided Ultrasound Surgery,” IEEE Trans. On Ultrasonics, Ferroelectrics and Freq. Cont., vol. 44, No. 5, pp. 1157-1167 (Sep. 1997). |
Herbert et al., “Energy-based adaptive focusing of waves: application to ultrasonic transcranial therapy,” 8th Intl. Symp. On Therapeutic Ultrasound. |
Huber et al., “A New Noninvasive Approach in Breast Cancer Therapy Using Magnetic Resonance Imaging-Guided Focussed Ultrasound Surgery,” Cancer Research 61, 8441-8447 (Dec. 2001). |
International Preliminary Report on Patentability in International Patent Application No. PCT/IB2004/001512, mailed Dec. 8, 2005. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2004/001498, dated Aug. 31, 2004. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2005/002273, mailed Dec. 20, 2005. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2005/002413, mailed Nov. 22, 2005. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2006/001641, mailed Sep. 25, 2006. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2006/003300, mailed Feb. 14, 2008. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2007/001079, mailed Dec. 10, 2007. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2007/002134, mailed Dec. 13, 2007. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2007/002140, mailed Dec. 29, 2008. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2008/003069, mailed Apr. 27, 2009. |
Jolesz et al., “Integration of interventional MRI with computer-assisted surgery,” J. Magnetic Resonance Imaging. 12:69-77 (2001). |
Kohler et al., “Volumetric HIFU Ablation guided by multiplane MRI thermometry,” 8th Intl. Symp. On Therapeutic Ultrasound, edited by E.S. Ebbini, U. of Minn. (Sep. 2009). |
Kowalski et al., “Optimization of electromagnetic phased-arrays for hyperthermia via magnetic resonance temperature estimation,” IEEE Trans. On Biomed. Eng., vol. 49, No. 11, pp. 1229-1241 (Nov. 2002). |
Maxwell et al., “Noninvasive thrombolysis using pulsed ultrasound cavitation therapy—Histotripsy,” Abstract, U.S. Natl. Lib. of Med., NIH, Ultrasound Med. Biol. (Oct. 23, 2009). |
McDannold et al., “MRI evaluation of thermal ablation of tumors and focused ultrasounds,” JMRI vol. 8, No. 1, pp. 91-100 (1998). |
McDannold et al., “Magnetic resonance acoustic radiation force imaging,” Med. Phys. vol. 35, No. 8, pp. 3748-3758 (Aug. 2008). |
Medel et al., “Sonothrombolysis: An emerging modality for the management of stroke,” Neurosurgery, vol. 65, No. 5, pp. 979-993. |
Mougenot et al., “MR monitoring of the near-field HIFU heating,” 8th Intl. Symp. On Therapeutic Ultrasound, edited by E.S. Ebbini, U. of Minn. (Sep. 2009). |
Partial International Search Report and Written Opinion in International Patent Application No. PCT/IB2007/001079, dated Sep. 25, 2007. |
Vimeux et al., “Real-time control of focused ultrasound heating based on rapid MR thermometry,” Investig. Radiology, vol. 43, No. 3, pp. 190-193. |
Vykhodtseva et al., “MRI detection of the thermal effects of focused ultrasound on the brain,” Ultrasound in Med. & Biol., vol. 26, No. 5, pp. 871-880 (2000). |
Written Opinion in International Patent Application No. PCT/IL01/00340, mailed Feb. 24, 2003. |
Written Opinion in International Patent Application No. PCT/IL02/00477, mailed Feb. 25, 2003. |
Written Opinion in International Patent Application No. PCT/IB03/05551, mailed Sep. 10, 2004. |
“How is Ablatherm treatment performed?” http://www.edap-hifu.com/eng/physicians/hifu/3c—treatment treat-description.htm, accessed Jan. 3, 2003. |
“What is HIFU? HIFU: High Intensity Focused Ultrasound,” http://www.edap-hifu.com/eng/physicians/hifu2a—hifu—overview.htm, accessed Jan. 3, 2003. |
“What are the physical principles?” http://www.edap-hifu.com/eng/physicians/hifu/2c—hifu—physical.htm, accessed Jan. 3, 2003. |
“How does HIFU create a lesion?” http://www.edap-hifu.com/eng/physicians/hifu/2d—hifu—lesion.htm, accessed Jan. 3, 2003. |
“Prostate Cancer Phase I Clinical Trials Using High Intensity Focused Ultrasound (HIFU),” Focus Surgery, http://www.focus-surgery.com/PCT%20Treatmene%20with%20HIFU.htm, accessed Jan. 3, 2003. |
“Abstract” Focus Surgery, http://www.focus-surgery.com/Sanghvi.htm, accessed Jan. 3, 2003. |
Exablate 2000 Specification, InSightec, Ltd. (2 pages). |
FDA Approves Exablate 2000 as Non-invasive surgery for Fibroids, Oct. 22, 2004. |
International Search Report and Written Opinion in International Patent Application No. PCT/IB2010/000189, mailed Jun. 1, 2010. |
International Search Report for PCT/IB03/05551 completion date Mar. 2, 2004 (5 pages). |
International Search Report and Written Opinion in Intemation Patent Application No. PCT/IB2010/000971, mailed Jul. 29, 2010 (9 pages). |
McGough, et al., “Direct Computation of Ultrasound Phased-Array Driving Signals from a Specified Temperature Distribution for Hyperthermia,” IEEE Trans. On Biomedical Engineering, vol. 39, No. 8, pp. 825-835 (Aug. 1992). |
McDannold, et al., “Quality Assurance and System Stability of a Clinical MRI-guided focused ultrasound system: Four-year experience,” Medical Physics, vol. 33, No. 11, pp. 4307-4313 (Oct. 2006). |
Soher et al., “Correcting for BO Field Drift in MR Temperature Mapping with Oil References,” Proceedings of the Intl. Society for Magnetic Resonance in Medicine, (May 2008). |
International Search Report and Written Opinion issued Dec. 2, 2010 for International Application No. PCT/IB2010/044345 (11 pages). |
Number | Date | Country | |
---|---|---|---|
20110034800 A1 | Feb 2011 | US |